Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 0.5 mg - capsule, hard - excipient ingredients: gelatin; croscarmellose sodium; titanium dioxide; methyl chloride; iron oxide yellow; ethanol absolute; hypromellose; lactose; purified water; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; lactose; methyl chloride; titanium dioxide; hypromellose; magnesium stearate; ethanol absolute; purified water; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: methyl chloride; gelatin; magnesium stearate; purified water; ethanol absolute; hypromellose; titanium dioxide; croscarmellose sodium; lactose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 0.5 mg

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning , warnings and precautions: pediatric use ). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.